Increasing data showed that abnormal expression of GAS5 is involved in many kinds of cancers and its aberrant expression is associated with lung cancer [21], renal cell carcinoma [22], breast cancer [12], glioblastoma [23], and CRC [24]. This evidence concerns the gene GAS5 and lung cancer.